Lesley Goodburn lgoodbu - Bluesky Statics

Stress Nerves May Fuel Pancreatic Cancer Growth New research from OHSU points to an unexpected player in cancer research: nerves Ariana Sattler, Ph.D., is first author on a new study

www.miragenews.com/stress-nerve...

04.03.2026 06:34 — 👍 1 🔁 1 💬 0 📌 0

Discover What Lies Ahead for Immunotherapy- Cancer Research Institute - OncoDaily Discover What Lies Ahead for Immunotherapy- Cancer Research Institute / cancer, Cancer Research Institute, immunotherapy, OncoDaily, Oncology

oncodaily.com/opinion/immu...

04.03.2026 06:33 — 👍 0 🔁 0 💬 0 📌 0

Cancer charity announces new chief executive Paula Hanford has taken up the top job at Pancreatic Cancer Action

www.thirdsector.co.uk/cancer-chari...

04.03.2026 06:32 — 👍 0 🔁 0 💬 0 📌 0

Tributes paid as Bishop of Guildford Andrew Watson dies from pancreatic cancer The Rt Revd Andrew Watson, Bishop of Guildford, has died aged 64.

www.wokingnewsandmail.co.uk/news/tribute...

04.03.2026 06:31 — 👍 1 🔁 0 💬 0 📌 0

The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer Currently, no consensus exists regarding the definition of oligometastatic pancreatic ductal adenocarcinoma, its necessary diagnostic measures, and potential treatment approaches. To address these kno...

www.thelancet.com/journals/lan...

04.03.2026 06:30 — 👍 1 🔁 0 💬 0 📌 0

18F-FDG PET-CT Advances Staging of Lobular Breast Cancer In the relentless pursuit of advancing cancer diagnostics, a new chapter unfolds with a focus on the complexities surrounding locally advanced breast cancer (LABC). Among the diverse histological

bioengineer.org/18f-fdg-pet-...

04.03.2026 06:04 — 👍 0 🔁 0 💬 0 📌 0

Artios Reports Randomized Phase 2a Study of Low Dose Alnodesertib Plus Gemcitabine Achieves Primary Endpoint in Platinum-Resistant Ovarian Cancer Low dose alnodesertib plus gemcitabine met the primary endpoint of progression-free survival (PFS) versus gemcitabine alone in patients with platinum-resistant high-grade serous ovarian cancerStudy pr...

uk.finance.yahoo.com/news/artios-...

03.03.2026 05:28 — 👍 1 🔁 0 💬 0 📌 0

HIT cells, a new and promising avenue against pancreatic and ovarian cancers? The team of one of the pioneering researchers in immunotherapy proposes a therapeutic target present in all tumors, although at different levels

en.ara.cat/society/hit-...

02.03.2026 21:28 — 👍 0 🔁 0 💬 0 📌 0

Nicolas Ciattoni: A New Biomarker Strategy for Stage I Pancreatic Cancer - OncoDaily Nicolas Ciattoni: A New Biomarker Strategy for Stage I Pancreatic Cancer / Ann L. Oberg, Brianna M. Krusen, cancer, Erica L. Carpenter, Erin E. Carlson, Greg

oncodaily.com/voices/nicol...

02.03.2026 21:27 — 👍 0 🔁 0 💬 0 📌 0

Immuneering Touts 64% 12-Month Survival for Atebimetinib in Pancreatic Cancer, Eyes Phase 3 Immuneering (NASDAQ:IMRX) Chief Executive Officer and co-founder Ben Zeskind told attendees at Oppenheimer’s 36th Annual Healthcare Life Sciences Conference that the company is focused on improving su...

www.marketbeat.com/instant-aler...

02.03.2026 21:26 — 👍 0 🔁 0 💬 0 📌 0

PressReader.com - Digital Newspaper & Magazine Subscriptions Digital newsstand featuring 7000+ of the world’s most popular newspapers & magazines. Enjoy unlimited reading on up to 5 devices with 7-day free trial.

www.pressreader.com/ireland/iris...

02.03.2026 21:23 — 👍 0 🔁 0 💬 0 📌 0

AI metabolomics platform to advance pancreatic cancer early diagnosis New method to transcend single biomarker limitations

healthcare-in-europe.com/en/news/ai-m...

02.03.2026 21:21 — 👍 0 🔁 0 💬 0 📌 0

Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum - Communications Medicine Peterka et al. develop a noninvasive blood-based lipidomic test that distinguishes pancreatic cancer patients from healthy controls. The test achieves >95% accuracy, detects early-stage disease, sh...

www.nature.com/articles/s43...

02.03.2026 21:20 — 👍 0 🔁 0 💬 0 📌 0

A molecular 'switch' could make pancreatic cancer more treatable Scientists at Duke-NUS Medical School have identified a molecular "switch" that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some o...

medicalxpress.com/news/2026-03...

02.03.2026 21:19 — 👍 0 🔁 0 💬 0 📌 0

Article | WVU Medicine Article not found or unavailable.

wvumedicine.org/news/article/

02.03.2026 21:18 — 👍 0 🔁 0 💬 0 📌 0

It took months to get Dad's diagnosis - he died just 6 days later The last thing he said to me was: 'Love you too'.

metro.co.uk/2026/02/28/t...

02.03.2026 20:54 — 👍 0 🔁 0 💬 0 📌 0

Prospective study on 18F-FDG PET-CT for staging locally advanced invasive lobular breast carcinoma - British Journal of Cancer British Journal of Cancer - Prospective study on 18F-FDG PET-CT for staging locally advanced invasive lobular breast carcinoma

www.nature.com/articles/s41...

02.03.2026 20:53 — 👍 0 🔁 0 💬 0 📌 0

A promising new drug for an invasive type of breast cancer EPFL researchers have developed preclinical models for invasive lobular carcinoma and trialed a new drug. It slows tumor growth effectively by targeting specific features of the disease and opening th...

actu.epfl.ch/news/a-promi...

02.03.2026 12:08 — 👍 1 🔁 0 💬 0 📌 0

Study reveals pancreatic cancer's early immune evasion tactics A new study suggests that pancreatic cancer may start preparing to "hide" from the immune system long before the disease becomes full-blown cancer.

www.news-medical.net/news/2026022...

28.02.2026 03:08 — 👍 1 🔁 0 💬 0 📌 0

Vegetarian diet lowers risk of cancer, Oxford study finds The new study - led by University of Oxford researchers - is the largest ever of its kind.

www.bbc.com/news/article...

28.02.2026 03:07 — 👍 0 🔁 0 💬 0 📌 0

“Pioneering” p53 Reactivator Shows Proof-of-Concept in Phase I Trial Findings from a phase I study show that the p53 reactivator rezatapopt is safe and can elicit responses in patients with a range of solid tumors containing the Y220C mutation. Although the drug was in...

aacrjournals.org/cancerdiscov...

28.02.2026 03:05 — 👍 0 🔁 0 💬 0 📌 0

Revolution spreads its PRMT5 bet

www.oncologypipeline.com/apexonco/rev...

28.02.2026 03:04 — 👍 0 🔁 0 💬 0 📌 0

Clearnote's blood test uses AI to spot high-risk pancreatic cancer Clearnote Health has launched an AI-powered blood test to detect pancreatic cancer early in people at high risk.

rarecancernews.com/news/clearno...

28.02.2026 03:02 — 👍 0 🔁 0 💬 0 📌 0

www.nature.com/articles/s41...

28.02.2026 03:02 — 👍 0 🔁 0 💬 0 📌 0

Northwell Study Shows AI Tool iNav Cuts Pancreatic Cancer Diagnosis Time in Half Northwell Health’s artificial intelligence tool, iNav, is demonstrating measurable impact in one of oncology’s most challenging areas: pancreatic cancer detection. According to a study published in Th...

hlth.com/insights/new...

28.02.2026 03:01 — 👍 0 🔁 0 💬 0 📌 0

Pancreatic cancer may begin hiding from the immune system earlier than we thought A new study suggests that pancreatic cancer may start preparing to “hide” from the immune system long before the disease becomes full-blown cancer. Researchers found that very early, preca...

www.eurekalert.org/news-release...

28.02.2026 03:00 — 👍 0 🔁 0 💬 0 📌 0

Breast Cancer and the Think Pink Movement! Breast cancer impacts 1 in 8 women, which is why education and awareness matter more than ever.

www.hercampus.com/school/usf/b...

28.02.2026 02:59 — 👍 0 🔁 0 💬 0 📌 0

Immunomodulation of Pancreatic Cancer via Inhibition of SUMOylation and the CD155/TIGIT Pathway Abstract. Pancreatic ductal adenocarcinoma (PDAC) is the deadliest major cancer and has a profoundly immunosuppressive tumor microenvironment (TME). Previous studies have shown that inhibition of the ...

aacrjournals.org/mct/article/...

27.02.2026 09:31 — 👍 0 🔁 0 💬 0 📌 0

Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralised oncology service - British Journal of Cancer British Journal of Cancer - Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralised oncology service

www.nature.com/articles/s41...

27.02.2026 09:31 — 👍 0 🔁 0 💬 0 📌 0

More Sensitive Cell Therapy May Be a HIT Against Solid Cancers HIT cells—a close cousin to CAR-T cells—eradicate kidney, pancreatic, and ovarian cancers in mice and could remove a major impediment to cell therapy against many solid tumors.

www.cuimc.columbia.edu/news/more-se...

27.02.2026 09:24 — 👍 0 🔁 0 💬 0 📌 0

Posts by Lesley Goodburn (@lgoodbu.bsky.social)